openPR Logo
Press release

Pioneering Wellness: Unraveling the Neuromodulation Devices Market 2023-2030 Landscape, Business Strategies, Share, Value of Revenue Analysis, Size Growth Insights | Bioventus, Neuronetics, NEVRO CORP, Integer Holdings Corporation

12-27-2023 08:02 AM CET | Health & Medicine

Press release from: Coherent Market Insights

Neuromodulation Devices Market

Neuromodulation Devices Market

Market Overview:

Neuromodulation devices are medical devices used for the treatment of neurological disorders such as chronic pain, Parkinson's disease, epilepsy, depression, dystonia etc. These devices deliver electrical or chemical stimuli to targeted areas of the nervous system for regulating neurological functions.

The global neuromodulation devices market is estimated to be valued at US$ 14.1 billion in 2023 and is expected to exhibit a CAGR of 15.2% during the forecast period (2023-2030).

Market Dynamics:

Rising prevalence of neurological disorders is expected to drive the growth of neuromodulation devices market over the forecast period. According to the National Institutes of Health (NIH), more than 1 billion people worldwide suffer from neurological disorders. Furthermore, growing geriatric population is also susceptible to neurological disorders which is expected to boost the market growth. According to the WHO, the proportion of the world's population over 60 years will nearly double from 12% to 22% between 2015 and 2050. Additionally, increasing R&D investments by key players for development of innovative neuromodulation devices is also expected to fuel the market growth during this period.

Major Driver: Growing Prevalence of Neurological Disorders

The Global Neuromodulation Devices Market is being driven by the growing prevalence of neurological disorders worldwide. Diseases such as Parkinson's disease, epilepsy, depression, migraine, chronic pain etc. are on the rise globally due to factors such as increasing stress levels, unhealthy lifestyle habits, genetic predispositions etc. Neurological disorders not only have a huge impact on the quality of life of patients but also place a significant economic burden on healthcare systems and families. Neuromodulation devices are proving to be an effective treatment option for many such conditions by regulating abnormal neural activity. As the number of such cases continue to surge, the demand for neuromodulation therapies and associated devices is witnessing strong growth.

๐๐ฎ๐ฒ ๐“๐ก๐ข๐ฌ ๐๐ซ๐ž๐ฆ๐ข๐ฎ๐ฆ ๐‘๐ž๐ฉ๐จ๐ซ๐ญ ๐š๐ง๐ ๐†๐ž๐ญ ๐”๐ฉ๐ญ๐จ ๐Ÿ’๐Ÿ“ % ๐Ž๐…๐…: https://www.coherentmarketinsights.com/insight/buy-now/3861

Driver: Technological Advancements in Neuromodulation Devices

Technological innovation has been a major catalyst for the neuromodulation devices market. Advancements such as smaller and more powerful battery systems, improved programming and efficacy of stimulation, wireless connectivity options, targeted therapy options etc. have enhanced the effectiveness and appeal of these devices. Newer generations of devices offer features like remotely controlled therapeutic adjustments, compatibility with brain imaging for personalized programming, adaptability as per changing symptoms etc. Rising R&D investments by manufactures is helping to expand the scope of neuromodulation therapies for a wider range of health issues. Customized, cutting-edge devices with enhanced patient comfort and compliance are driving repeat purchases and new adoptions in the market.

Restrain: High Cost of Neuromodulation Procedures and Therapies

The high cost associated with neuromodulation procedures and continued therapy is a major limiting factor deterring widespread adoption. Implantable devices have considerable price tags while surgical implantation and programming by trained physicians does not come cheap. Post-procedure maintenance, battery replacements and follow up sessions further increase the total cost of care which is a massive burden for many without comprehensive health coverage. In developing nations with vast underprivileged populations, affordability remains a big challenge restricting market penetration. Concerted efforts are needed to make these therapies more affordable and accessible through initiatives like favorable reimbursement policies, low cost alternatives, and awareness building.

Opportunity: Emerging Therapeutic Applications

The Global Neuromodulation Devices Market has promising growth opportunities arising from the evolving therapeutic applications of these technologies. New research studies are establishing the efficacy of neuromodulation techniques for a host of previously untreatable disorders. This includes conditions like obesity, substance abuse disorders, traumatic brain injury, Alzheimer's disease, smoking cessation etc. Expanding approval pathways will boost commercialization prospects in these areas. Similarly, cognitive health is garnering interest for neuromodulation interventions. Successful application in developmental fields like these opens lucrative revenue streams in the future. Companies wise enough to venture into newer niches early on stand to gain substantially.

Trend: Increasing Popularity of Non-invasive Neuromodulation Methods

A notable trend impacting the neuromodulation devices landscape is the rising popularity of non-invasive techniques versus conventional implantables. Complications associated with surgical procedures and long term implants have increased patient preference for non or minimally invasive options like transcranial magnetic stimulation (TMS), transcranial current stimulation (tCS) and focused ultrasound (FUS). These external approaches do not require insertion of foreign bodies, carry lower risks, avoid device replacement burdens and offer more cost-effective care over time. Key players are striving to gain first-mover advantage in developing non-invasive systems through heavy R&D spend. Widening clinical evidence backing external neuromodulation efficacy and safety is strengthening this emerging preference trend.

List of TOP Players in Market Report are: -

โ—˜ Medtronic
โ—˜ BD
โ—˜ LivaNova
โ—˜ Axonics Inc.
โ—˜ ShiraTronics
โ—˜ Abbott
โ—˜ Bioventus
โ—˜ Neuronetics
โ—˜ NEVRO CORP
โ—˜ Integer Holdings Corporation
โ—˜ BIOTRONIK
โ—˜ NeuroPace Inc.
โ—˜ NeuroMetrix Inc.
โ—˜ Helius Medical Technologies Inc.
โ—˜ Synapse Biomedical Inc.

Note: Major Players are sorted in no particular order.

๐๐ฎ๐ฒ ๐“๐ก๐ข๐ฌ ๐๐ซ๐ž๐ฆ๐ข๐ฎ๐ฆ ๐‘๐ž๐ฉ๐จ๐ซ๐ญ ๐š๐ง๐ ๐†๐ž๐ญ ๐”๐ฉ๐ญ๐จ ๐Ÿ’๐Ÿ“ % ๐Ž๐…๐…: https://www.coherentmarketinsights.com/insight/buy-now/3861

Furthermore, the years considered for the study are as follows:

Historical data - 2016-2021
The base year for estimation - is 2021
Estimated Year - 2023
Forecast period** - 2023 to 2030

This Neuromodulation Devices Market Research/Analysis Report Contains Answers to your following Questions:

โ—ˆWhat are the current global trends in the Neuromodulation Devices market, and will the market experience an increase or decrease in demand in the upcoming years?

โ—ˆ What is the expected demand for various product types within the Neuromodulation Devices market, and what are the emerging Market applications and trends?

โ—ˆ What are the projections for the global Neuromodulation Devices Market in terms of capacity, production, production value, cost, profit, market share, supply, consumption, import, and export?

โ—ˆ How will strategic developments shape the Market trajectory in the medium to long term?

โ—ˆ What factors contribute to the final price of Neuromodulation Devices , and what are the raw materials used in its manufacturing?

โ—ˆ What is the market's growth potential, particularly with the increasing adoption of Neuromodulation Devices in mining?

โ—ˆ What is the current and 2022 value of the global market, and who are the leading companies in this market?

โ—ˆ What recent Market trends can be leveraged to create additional revenue streams?

โ—ˆ What entry strategies, economic impact mitigation measures, and marketing channels should be considered for the Neuromodulation Devices Market?

Summarized Extracts from TOC of Market Study

Chapter 1 Neuromodulation Devices Introduction and Market Overview

1.1 Objectives of the Study

1.2 Overview of Neuromodulation Devices

1.3 Scope of The Study

1.3.1 Key Market Segments

1.3.2 Players Covered

1.3.3 COVID-19's impact on the Neuromodulation Devices industry

1.4 Methodology of The Study

1.5 Research Data Source

Chapter 2 Executive Summary

Chapter 3 Industry Chain Analysis

Chapter 4 Market, by Type

Chapter 5 Market, by Application

Chapter 6 Market Analysis by Regions

Chapter 7 North America Market Analysis by Countries

Chapter 8 Europe Neuromodulation Devices Market Analysis by Countries

Chapter 9 Asia Pacific Neuromodulation Devices Market Analysis by Countries

Chapter 10 Middle East and Africa Neuromodulation Devices Market Analysis by Countries

Chapter 11 South America Neuromodulation Devices Market Analysis by Countries

Chapter 12 Competitive Landscape

Chapter 13 Industry Outlook

Chapter 14 Market Forecast

Chapter 15 New Project Feasibility Analysis

Get an Exclusive Sample Copy of the Report at: - https://www.coherentmarketinsights.com/insight/request-sample/3861

Contact Us

Mr. Shah
Coherent Market Insights Pvt Ltd,
533 Airport Boulevard, Suite 400, Burlingame,
CA 94010, United States
Phone: US +12067016702 / UK +4402081334027
JAPAN:+81-50-5539-1737
INDIA:+91-848-285-0837
Email: sales@coherentmarketinsights.com

About Coherent Market Insights

Coherent Market Insights is a global market intelligence and consulting organization that provides syndicated research reports, customized research reports, and consulting services. We are known for our actionable insights and authentic reports in various domains including aerospace and defense, agriculture, food and beverages, automotive, chemicals and materials, and virtually all domains and an exhaustive list of sub-domains under the sun. We create value for clients through our highly reliable and accurate reports. We are also committed in playing a leading role in offering insights in various sectors post-COVID-19 and continue to deliver measurable, sustainable results for our clients.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Pioneering Wellness: Unraveling the Neuromodulation Devices Market 2023-2030 Landscape, Business Strategies, Share, Value of Revenue Analysis, Size Growth Insights | Bioventus, Neuronetics, NEVRO CORP, Integer Holdings Corporation here

News-ID: 3338471 • Views: โ€ฆ

More Releases from Coherent Market Insights

Current Sensor Market Set to Witness Significant Growth by 2025-2032 - Coherent Market Insights
Current Sensor Market Set to Witness Significant Growth by 2025-2032 - Coherent โ€ฆ
The Current Sensor market is estimated to be valued at USD 3.42 Bn in 2025 and is expected to reach USD 6.75 Bn by 2032, growing at a compound annual growth rate CAGR of 10.2% from 2025 to 2032. โžค Coherent Market Insights has published an in-depth research report titled "Current Sensor Market: Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2025-2032." This study offers a deep dive into the Currentโ€ฆ
U.S. Bodyguard Service & Security Consulting Market Evolution by 2032 - Disruptive Innovations, Regional Insights, and Growth Opportunities
U.S. Bodyguard Service & Security Consulting Market Evolution by 2032 - Disrupti โ€ฆ
The U.S. Bodyguard Service & Security Consulting market is estimated to be valued at USD 2.57 Bn in 2025 and is expected to reach USD 3.52 Bn by 2032, growing at a compound annual growth rate CAGR of 4.6% from 2025 to 2032. โžค Coherent Market Insights has published an in-depth research report titled "U.S. Bodyguard Service & Security Consulting Market: Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2025-2032." Thisโ€ฆ
Single Cell Sequencing Market Set for Dynamic Boom as Key Players Illumina, BD Biosciences, Pacific Biosciences, Thermo Fisher Scientific
Single Cell Sequencing Market Set for Dynamic Boom as Key Players Illumina, BD B โ€ฆ
The qualitative latest Research report (2025-2032) on the Single Cell Sequencing Market 2025 - 2032 by Coherent Market Insights Provides a deep dive into key market trends, drivers, challenges, and the competitive landscape. It analyzes market size, revenue, production, and CAGR using validated methodologies to ensure precision. The report highlights tech innovation, pricing trends, consumer behavior, and investment potential - empowering businesses to make informed, strategic moves. โžค Request a Sampleโ€ฆ
Nuclear Medicine Equipment Market Set for Demonstrate Strong Growth During 2025-2032 with Key Players GE Healthcare, Siemens Healthineers, Philips, and Canon Medical Systems
Nuclear Medicine Equipment Market Set for Demonstrate Strong Growth During 2025- โ€ฆ
The qualitative latest Research report (2025-2032) on the Nuclear Medicine Equipment Market 2025 - 2032 by Coherent Market Insights Provides a deep dive into key market trends, drivers, challenges, and the competitive landscape. It analyzes market size, revenue, production, and CAGR using validated methodologies to ensure precision. The report highlights tech innovation, pricing trends, consumer behavior, and investment potential - empowering businesses to make informed, strategic moves. โžค Request a Sampleโ€ฆ

All 5 Releases


More Releases for Neuromodulation

Neuromodulation Market worth $10.4 billion by 2027
Neuromodulation Market is projected to grow from USD 6.0 billion in 2022 to USD 10.4 billion by 2027, at a CAGR of 11.8% from 2022 to 2027, according to a new report by MarketsandMarketsโ„ข. The market is driven by government support for research on neurological disorder along with increasing prevalence of neurological disorders. Emerging economies are expected to provide lucrative growth opportunities for the market. Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=921&utm_source=Openpr&utm_campaign=Paid&utm_content=Referral The internal neuromodulationโ€ฆ
Neuromodulation Market worth $11.0 billion by 2028
Browse 195 market data Tables and 39 Figures spread through 210 Pages and in-depth TOC on "Neuromodulation Market by Type (Internal (Spinal Cord Stimulation, Deep Brain Stimulation), External (Transcranial Magnetic Stimulation), Application (Tremor, Epilepsy, Parkinson's Disease, Depression, Gastroparesis), and Region - Global Forecast to 2028 Neuromodulation Market in terms of revenue was estimated to be worth $6.2 billion in 2023 and is poised to reach $11.0 billion by 2028, growing atโ€ฆ
Neuromodulation Market: Charting Future Frontiers for 2030
The Neuromodulation market was valued USD 6.5 Billion in 2023 and projected to reach USD 15.3 Billion by 2030, growing at a CAGR of 13.0% during the forecast period of 2024-2030. The Neuromodulation Market report studies the competitive environment of the Neuromodulation Market based on company profiles and their efforts to increase product value and production. The Neuromodulation Market report discusses various factors driving or restraining the market, which will helpโ€ฆ
Incontinence Neuromodulation Market - Reclaiming Independence, Redefining Well-b โ€ฆ
Newark, New Castle, USA: The "Incontinence Neuromodulation Market" provides a value chain analysis of revenue for the anticipated period from 2023 to 2031. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors. Incontinence Neuromodulation Market: https://www.growthplusreports.com/report/incontinence-neuromodulation-market/8696 This latest report researches the industry structure, sales, revenue,โ€ฆ
Neuromodulation Devices Market Insights, Forecast to 2030
The report extensively examines the global Neuromodulation Devices market while focusing on the leading companies and their business strategies, geographical growth, market segmentation, competitive environment, production, price, and cost structures. Each section of the research report has been carefully designed to examine important facets of the global market for Neuromodulation Devices . For instance, the market dynamics section delves deeply into the trends, opportunities, and drivers influencing the global marketโ€ฆ
Neuromodulation Market Outlook 2022-2028
Neurological issues are characterized as problems that influence the mind as well as the nerves tracked down all through the human body and the spinal rope. Intense spinal line injury, Alzheimer's sickness, amyotrophic horizontal sclerosis (ALS), ataxia, chime paralysis, mind cancers, cerebral aneurysm, epilepsy, and seizures are a portion of the normal neurological issues. The biochemical, underlying, or electrical irregularities in the mind, spinal line, or different nerves bring aboutโ€ฆ